PRILENAP HL

Tablet, 10mg + 12.5mg
RxActive license

Active substance (INN)

enalaprilhydrochlorothiazide

Pharmaceutical form

Pharmaceutical formTablet
Strength10mg + 12.5mg
PackagingUkupno 30 tableta u blisteru (3x10) u kartonskoj kutiji
ManufacturerHemofarm a.d. Vršac, Serbia
Therapeutic groupCardiovascular system (C09BA02)
Marketing authorization holderDRUŠTVO SA OGRANIČENOM ODGOVORNOŠĆU "HEMOMONT" ZA PROIZVODNJU FARMACEUTSKIH PROIZVODA PODGORICA
Authorization dateFebruary 8, 2024

Analogs in Montenegro

20

Other medicines with the same active substance

Source: CInMED register